A retiring or transitioning podiatrist has 12–24 months of preparation work standing between a mediocre exit and a premium valuation. Use this checklist to identify gaps, fix value killers, and command the 3x–5.5x EBITDA multiple your practice deserves.
Selling a podiatry practice is fundamentally different from selling a general business. Buyers — whether an individual podiatrist, a healthcare-focused search fund operator, or a private equity-backed specialty platform — will scrutinize your payer mix, billing compliance history, physician dependency, and operational infrastructure with the same rigor applied to a hospital acquisition. The single biggest value killer in podiatry practice sales is a practice that lives and dies with the selling physician: one where every patient relationship, every referral from a primary care doctor or endocrinologist, and every dollar of collections is tied to you personally. The exit readiness process is designed to systematically reduce that dependency, document enterprise-level value, and present a practice that a buyer can finance through an SBA 7(a) loan and operate confidently after you step back. Start this process at least 18–24 months before your target close date. Practices that begin preparation early consistently achieve higher multiples, cleaner due diligence, and faster time to close.
Get Your Free Podiatry Practice Exit ScoreCompile 3 years of clean financial statements and tax returns
Gather profit and loss statements, balance sheets, and practice tax returns for the last three fiscal years. Ensure they are prepared or reviewed by a CPA familiar with healthcare practice accounting. Buyers and SBA lenders will require these as the foundation of any valuation conversation.
Document all physician compensation addbacks clearly
Identify and separately document all owner-physician compensation above a fair-market replacement salary, personal vehicle expenses, personal insurance premiums, retirement contributions, and any discretionary spending run through the practice. These addbacks directly increase your adjusted EBITDA and therefore your sale price. A podiatry practice earning $300K in stated net income may have $500K+ in true seller's discretionary earnings once addbacks are applied.
Separate personal expenses commingled with practice financials
Work with your accountant to reclassify or remove personal expenditures from practice books for at least the two most recent full fiscal years. Common examples in podiatry practices include personal cell phone plans, non-clinical subscriptions, family member payroll with minimal duties, and personal travel coded as CME.
Build a clean accounts receivable aging report
Generate an AR aging report broken down by payer category — Medicare, Medicaid, commercial insurance, and self-pay — with aging buckets at 30, 60, 90, and 120+ days. Buyers will scrutinize AR quality closely because podiatry practices treating high volumes of diabetic and elderly patients often carry elevated Medicare AR that is vulnerable to audit adjustments.
Benchmark your payer mix against acquisition targets
Calculate the exact percentage of annual collections attributable to Medicare, Medicaid, commercial insurers, and self-pay. Buyers targeting podiatry practices prefer Medicare concentration below 60% and Medicaid below 20%. If your mix is heavily weighted toward government payers, begin actively credentialing with additional commercial insurers now to shift the mix before going to market.
Conduct an internal billing and coding compliance audit
Engage a healthcare billing compliance consultant or attorney to audit a statistically significant sample of claims — particularly for high-volume podiatric codes including routine foot care (CPT 11055–11057), diabetic foot exams (G0247), orthotics (L3000 series), and surgical procedures. Identify any patterns of upcoding, unbundling, or inadequate documentation that could create Medicare overpayment exposure.
Resolve any outstanding insurance disputes, claim denials, or audit findings
Clear the decks on any pending payer audits, Medicare Advantage claim disputes, or Medicaid recoupment demands. Buyers performing due diligence will request a representation from you that no material billing investigations are pending. Unresolved items become negotiating leverage for buyers to reduce price or require significant escrow holdbacks.
Review and document denial rates and clean claim rates by payer
Pull 12 months of claims data to calculate your clean claim rate (percentage of claims paid on first submission) and denial rate by payer. Industry benchmark for a well-run podiatry practice is a clean claim rate above 90%. Document the steps taken to remediate any payer-specific denial patterns, particularly around Medicare medical necessity documentation for routine foot care in diabetic patients.
Confirm all EHR and practice management systems are current and transferable
Assess whether your electronic health records platform — whether Modernizing Medicine, WebPT, Epic, or a podiatry-specific system — is on a supported version with a transferable software license or cloud-based subscription. Buyers are highly sensitive to EHR replacement costs, which can run $50K–$150K for a single-location podiatry practice. An outdated or unsupported system is a direct deduction from your purchase price.
Recruit or formalize the role of an associate podiatrist or mid-level provider
If you are the sole provider, the single highest-impact action you can take is hiring or formalizing an associate podiatrist (DPM) or a physician assistant with podiatric training who generates revenue independently. Buyers will pay a significant premium for a practice where revenue is not 100% physician-dependent. Even a part-time associate generating 20–30% of collections transforms the risk profile of your practice in a buyer's eyes.
Create a comprehensive operational manual
Document clinical protocols for your highest-volume service lines — diabetic foot care, wound care, orthotics fitting and billing, nail procedures, and pre/post-operative surgical protocols. Include front desk procedures, appointment scheduling workflows, insurance verification steps, and patient recall systems for chronic care patients. Buyers need to see that the practice can function without you in the building.
Develop a diabetic foot care and wound care program documentation package
Podiatry practices with established, documented chronic care programs — including Medicare Annual Wellness Visit integration, diabetic shoe programs (HCPCS A5500 series), and wound care protocols — command premium valuations because these programs generate predictable, recurring revenue. Compile patient volume data, revenue per program, and documentation of referral relationships that drive program enrollment.
Cross-train clinical and administrative staff to reduce physician dependency
Identify which front desk, medical assistant, and billing staff roles are critical to daily operations and ensure at least two employees are trained in each key function. Buyers are acutely aware that a staff exodus post-acquisition is a real risk in podiatry practices where staff loyalty is tied to the owner-physician. Document staff tenure, compensation, and their ability to operate independently.
Ensure all provider credentialing, DEA registrations, and state licenses are current
Confirm that your DPM license, DEA registration, Medicare and Medicaid provider numbers, and all commercial payer credentialing are active, in good standing, and not facing any pending disciplinary action. Pull your National Practitioner Data Bank report proactively. Buyers will require clean credentialing as a condition of closing, and any lapse or pending action can delay or kill a deal.
Engage a healthcare M&A attorney to assess your state's corporate practice of medicine laws
Many states — including California, Texas, and New York — restrict non-physician ownership of medical practices through corporate practice of medicine (CPOM) doctrines. Your M&A attorney must assess whether your state's CPOM rules affect who can buy your practice and how the transaction must be structured. This is especially critical if your buyer is a DSO platform, private equity group, or search fund operator without a licensed podiatrist as the acquiring entity.
Review all employee agreements, non-solicitation clauses, and confirm key staff retention plans
Audit existing employment agreements for your associate podiatrist, office manager, billing staff, and clinical support staff. Identify any agreements without non-solicitation provisions — a serious concern if an associate could take patients to a competing practice post-sale. Buyers will want to see that key employees have been informed of a potential transition and are committed to staying on.
Assess and secure your facility lease terms
Review your current office lease for remaining term, renewal options, assignment rights, and landlord consent requirements for a change of ownership. Buyers — particularly those using SBA financing — typically require a minimum of 5–10 years of remaining lease term (including options) to underwrite the deal. Begin lease renegotiation or extension discussions with your landlord at least 12–18 months before your target sale date.
Conduct a HIPAA compliance review and confirm business associate agreements are in place
Buyers performing healthcare M&A due diligence will audit your HIPAA compliance posture, including your privacy policies, security risk assessment documentation, staff training records, and executed Business Associate Agreements with all third-party vendors — billing services, EHR vendors, transcription services, and IT support providers. A documented, current HIPAA compliance program signals to buyers that there is no latent regulatory liability.
Document all referral source relationships and transition them to the practice brand
Create a written inventory of your top 20–30 referring providers — primary care physicians, endocrinologists, vascular surgeons, orthopedic surgeons, and wound care centers — including relationship tenure, referral volume by year, and how referrals are received (fax, EMR integration, phone). Begin actively co-branding these relationships with your practice name rather than your personal name, including co-marketing materials, joint patient events, and introductions to your associate provider.
Implement a structured patient recall and chronic care management system
If you do not already have an automated patient recall system for your diabetic foot care, wound care, and orthotics patient populations, implement one now. Buyers value predictable, recurring appointment volume. Document your annual recall contact rates, no-show rates, and active patient count (patients seen within the last 18 months) to demonstrate a loyal, stable patient base.
Develop a physician transition and earnout plan
Work with your M&A advisor and attorney to design a post-sale transition plan that keeps you engaged in the practice for 12–24 months at a negotiated salary. Buyers — particularly SBA borrowers and DSO platforms — will require seller transition involvement. A well-structured earnout tied to patient retention and revenue targets over 12–24 months can add $100K–$300K to total deal consideration while protecting the buyer's downside.
Prepare a confidential information memorandum (CIM) with your M&A advisor
A professionally prepared CIM — including a practice overview, financial summary, payer mix analysis, service line breakdown, staffing summary, facility details, and growth opportunities — is the primary marketing document buyers will review before submitting a letter of intent. In the podiatry M&A market, practices that go to market with a polished CIM signal professionalism and attract better-qualified buyers, including DSO platforms and search fund operators who move quickly.
See What Your Podiatry Practice Business Is Worth
Free exit score, valuation range, and personalized action plan — 5 minutes.
The full exit process for a podiatry practice — from beginning exit preparation to receiving proceeds at closing — typically takes 18–24 months when done properly. The preparation phase alone, which includes financial cleanup, billing compliance audits, lease negotiations, and operational documentation, should begin at least 12–18 months before you plan to go to market. Once you actively begin marketing the practice, expect 3–6 months to identify a qualified buyer and execute a letter of intent, followed by 60–120 days of due diligence and financing before closing. Practices that rush to market without adequate preparation routinely take longer to sell, receive lower offers, and experience deal failures during due diligence.
Podiatry practices in the lower middle market typically sell for 3x–5.5x adjusted EBITDA. The specific multiple your practice commands depends on several factors: the degree to which revenue is concentrated in you as the sole physician (lower multiples for single-physician practices), your payer mix quality (higher commercial insurance concentration supports higher multiples), the presence of an associate provider, your billing compliance history, and the strength of your referral network at the practice level. A podiatry practice generating $500K in adjusted EBITDA with an associate physician, diversified payer mix, and clean compliance history might sell for $2.0M–$2.75M. The same practice with no associate and 75% Medicare concentration might receive offers of $1.5M–$1.75M or lower.
This depends entirely on your state's corporate practice of medicine (CPOM) laws. In states with strict CPOM doctrines — including California, Texas, Illinois, and New York — non-physician entities cannot directly own a medical practice. However, buyers such as private equity-backed DSO platforms and search fund operators routinely navigate CPOM restrictions through management services organization (MSO) structures, where a physician-owned professional entity retains the clinical entity and a separate management company owned by non-physicians handles administrative and business functions. If you are in a CPOM state, your buyer pool is not necessarily limited, but the deal structure will be more complex and will require experienced healthcare M&A legal counsel on both sides.
Patient continuity is the most common concern among selling podiatrists and is also the most important variable buyers underwrite when making an offer. If you stay involved in the practice during a 12–24 month transition period — as most buyers require — patient retention is typically very high, often exceeding 85–90%. The keys to protecting patient relationships post-sale are: maintaining your personal involvement through the transition, introducing patients to your associate or successor physician before your departure, ensuring the practice name and phone number remain unchanged, and implementing a structured patient communication plan at the time of the sale announcement. Practices where the selling physician abruptly departs at closing experience much higher patient attrition, which is why most buyers structure earnout payments tied to post-close revenue retention.
Yes, podiatry practices are well-suited for SBA 7(a) financing, and the majority of smaller practice acquisitions in the $500K–$3M purchase price range are financed this way. A typical SBA-financed podiatry acquisition requires the buyer to inject 10–15% equity, with the remaining 85–90% financed through the SBA 7(a) program at a 10-year term. Lenders will require 3 years of practice tax returns, a minimum debt service coverage ratio of approximately 1.25x, a lease term of at least 10 years including options, and clean provider credentialing. As a seller, you may be asked to hold a seller note equal to 5–10% of the purchase price, which is subordinated to the SBA loan and paid out over 2–3 years. Sellers who have their financial documentation, lease, and compliance records in order materially accelerate the SBA underwriting timeline.
Staff retention during a practice ownership transition is a legitimate concern, particularly for long-tenured clinical assistants and office managers whose loyalty is tied to you personally. The most effective approach is to keep the sale process confidential among a small circle (yourself, your M&A advisor, and your attorney) until a letter of intent is signed and due diligence is substantially complete. At that point, buyers will want to meet key staff members and may offer retention bonuses or employment agreement upgrades as part of the closing process. Before going to market, review existing staff employment agreements to ensure non-solicitation provisions are in place, document each role's responsibilities, and identify your two or three most critical employees whose retention should be a condition of closing.
Both buyer types have meaningful tradeoffs. An individual podiatrist buyer — whether a recent graduate or an associate looking to become an owner — typically offers a cleaner cultural fit and will operate the practice as a standalone entity. However, individual buyers often have less acquisition experience, require more hand-holding through the financing process, and may offer lower multiples. A private equity-backed specialty platform or DSO pursuing a roll-up strategy in lower extremity care may offer a higher upfront multiple — sometimes 5x–5.5x EBITDA or more — plus an equity rollover opportunity where you retain 20–30% ownership in the larger platform. The rollover equity can be highly valuable if the platform successfully exits to a larger acquirer or goes public, but it also means your wealth remains at risk. The right choice depends on your financial needs, your timeline, your interest in ongoing involvement, and your comfort with the complexity of PE-backed deal structures.
More Podiatry Practice Seller Guides
More Exit Checklists
Get your Podiatry Practice exit score, estimated valuation, and a step-by-step action plan — free, in 5 minutes.
Start Your Free Exit AssessmentFree forever · No broker needed · Takes 5 minutes
For Buyers
For Sellers